| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.04 | 0.8 |